Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010)
- PMID: 34708447
- PMCID: PMC9298349
- DOI: 10.1111/iju.14731
Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010)
Abstract
Objectives: To assess temporal patterns and regional differences in the incidence rate, and factors associated with survival of urinary tract urothelial carcinoma.
Methods: The medical records of 8830 patients with new diagnoses of urinary tract urothelial carcinoma in the years 2001-2010 were retrieved from Taiwan National databases. Temporal trends, regional disparity and related survival factors were evaluated using the Cochran-Armitage trend test, local Moran's I statistic and log-rank test, respectively.
Results: The annual urinary tract urothelial carcinoma incidence rates (standardized by age) were steady at approximately 3.14-3.41 per 100 000 person-years. Notably, women had a significantly higher annual urinary tract urothelial carcinoma incidence than men in most of the years studied (range of female-to-male annual standardized rate ratio: 2.08-3.25), and diabetes prevalence in urinary tract urothelial carcinoma increased significantly from 12.3% to 23.4% per year over the 10 years. High urinary tract urothelial carcinoma incidence cluster areas other than the latest endemic area of "blackfoot disease" were newly identified by local Moran's I statistic (P < 0.05). Furthermore, older age, male sex, end-stage kidney disease and more advanced tumor grade were associated with lower 5-year overall survival probabilities in the 2001-2015 cohort.
Conclusions: The incidence and survival of urinary tract urothelial carcinoma over the decade 2001-2010 were different according to population and regional features. Various urinary tract urothelial carcinoma screening, prevention, treatment and care plans should be developed depending on age, sex, comorbidity and area of residence.
Keywords: geographic variation; incidence; survival; trends; upper tract urothelial carcinoma.
© 2021 The Authors. International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.
Conflict of interest statement
None declared.
Figures
References
-
- Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J. Urol. 2000; 164: 1523–5. - PubMed
-
- Wihlborg A, Johansen C. Incidences of kidney, pelvis, ureter, and bladder cancer in a nationwide, population‐based cancer registry, Denmark, 1944–2003. Urology 2010; 75: 1222–7. - PubMed
-
- Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int. 2011; 107: 1059–64. - PubMed
-
- Cauberg ECC, Salomons MA, Kümmerlin IPED et al. Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995–2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int. 2010; 105: 922–7. - PubMed
-
- Woodford R, Ranasinghe W, Aw HC, Sengupta S, Persad R. Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria‐Australia. BJU Int. 2016; 117(S4): 45–9. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
